Avainsana: vaccine
Once a COVID-19 vaccine is found, what happens next?
Amid talk of vaccine nationalism, news of countries hoarding Covid-19 medication, and vaccine hesitancy, many fail to see the potential good news. Currently, there are…
Once a COVID-19 vaccine is found, what happens next?
Amid talk of vaccine nationalism, news of countries hoarding Covid-19 medication, and vaccine hesitancy, many fail to see the potential good news. Currently, there are…
Coronavirus vaccine put to final test in US in thousands of volunteers
A subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for Covid-19 at the Kaiser Permanente Washington…
U.S. drugmaker earnings heat up this week with spotlight on vaccine news
Several major U.S. drugmakers will report second-quarter results this week, with investors eager for fresh details from Pfizer Inc (PFE.N), Merck & Co (MRK.N) and…
US doubles spending on potential virus vaccine to nearly $1 billion
The United States has doubled its investment — to nearly $1 billion — to expedite development of a potential COVID-19 vaccine by American firm Moderna,…
Vaccine could be ready for Christmas, says UK health minister
Britain’s health minister Matt Hancock said on Tuesday that under the “best-case scenario” a COVID-19 vaccine will be ready for Christmas. Answering questions from the…
Covid-19 vaccine developed by US biotech firm Moderna enters final stage trial
US biotech firm Moderna said Tuesday it would enter the final stage of human trials for its COVID-19 vaccine on July 27, to test how…
Coronavirus: Fewer Germans willing to get vaccinated, survey shows
Just over 60% of people in Germany would be willing to get vaccinated against COVID-19, a new survey has found. For researchers, the staunch opponents…
J&J moves up start of coronavirus vaccine human trials to July
Johnson & Johnson moved up the start of human clinical trials for its experimental vaccine against the highly contagious coronavirus by two months to the…
Coronavirus vaccine: AstraZeneca boosts potential supply to 2bn
AstraZeneca said it will be able to supply two billion doses of a potential virus vaccine following two new deals. Last month, AstraZeneca said it could…
Finnish site 
Global site